Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
<h4>Aims</h4>Inflammation plays a pivotal role in atherothrombosis. Colchicine is an anti-inflammatory drug that may attenuate this process. Cardiovascular protective effects of anti-inflammatory drugs, however, seem to be limited to patients with a biochemical response. We therefore inv...
Main Authors: | Aernoud T L Fiolet, Max J M Silvis, Tjerk S J Opstal, Willem A Bax, Frans A L van der Horst, Arend Mosterd, Dominique de Kleijn, Jan H Cornel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0237665 |
Similar Items
-
Colchicine: an emerging treatment for coronary artery disease
by: Waseem Hijazia, et al.
Published: (2021-08-01) -
High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome
by: Mirthe Dekker, et al.
Published: (2021-09-01) -
Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes—The Bumpy Road to Clinical Implementation
by: Mirthe Dekker, et al.
Published: (2020-11-01) -
Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned
by: Max J. M. Silvis, et al.
Published: (2021-04-01) -
Colchicine binding activity of wild type and colchicine resistant mutants of Chlamydomonas Reinhardi
by: Flanagan, D. J.
Published: (1981)